Sheikh S, Madiraju K, Steiner P, Rao M
Children's Medical Center, Health Science Center, State University of New York at Brooklyn, USA.
Chest. 1997 Nov 5;112(5):1202-7. doi: 10.1378/chest.112.5.1202.
There are several reports of the pulmonary findings in children with HIV disease; however, the occurrence of bronchiectasis rarely has been noted. We evaluated occurrence of bronchiectasis in a large group of children referred to us with AIDS pneumopathy.
From January 1984 to April 1996, 203 children with AIDS and respiratory problems were referred to the pediatric pulmonary division at Children's Medical Center of Brooklyn. Medical records for 164 of these children were available and retrospectively reviewed.
Uncomplicated pneumonia was present in 75, 24 had recurrent pneumonia, and 18 had unresolved pneumonia; lymphocytic interstitial pneumonitis (LIP) was diagnosed in 47 patients, worsening with time in all patients. Bronchiectasis was observed in 26 patients (26/164, 15.8%), diagnosed by chest radiograph in 26 (26/26, 100%), confirmed by CT scan of chest in 10 (10/26, 38.4%), and by histology in three (3/26, 11.5%). Median age at time of diagnosis of bronchiectasis was 7.5 years (range, 1 to 16 years). Sixteen children with LIP developed bronchiectasis (16/47, 34.0%). Three patients with recurrent pneumonia (3/24, 12.5%) developed bronchiectasis. Five patients with unresolved pneumonia (5/18, 27.7%) developed bronchiectasis. One infant developed bronchiectasis after Pneumocystis carinii pneumonia; another child developed bronchiectasis after P. carinii and Mycobacterium tuberculosis pneumonia. The CD4+ T-cell counts measured within 6 months of diagnosis of bronchiectasis were available in 23/26 patients and, all were < 100 cells per cubic millimeter.
We conclude, from our experience, that there is a significant occurrence of bronchiectasis in children with AIDS and pulmonary disease, especially in children developing LIP, recurrent pneumonia and unresolved pneumonia, and CD4+ T-cell counts < 100 cells per cubic millimeter.
已有多篇关于感染人类免疫缺陷病毒(HIV)儿童肺部表现的报道;然而,支气管扩张症的发生却鲜有提及。我们评估了一大群因艾滋病肺病变前来就诊的儿童中支气管扩张症的发生率。
1984年1月至1996年4月,203名患有艾滋病且有呼吸问题的儿童被转诊至布鲁克林儿童医疗中心的儿科肺病科。其中164名儿童的病历资料可供回顾性分析。
75名儿童患有单纯性肺炎,24名有复发性肺炎,18名有未愈肺炎;47名患者被诊断为淋巴细胞间质性肺炎(LIP),所有患者病情均随时间恶化。26名患者(26/164,15.8%)出现支气管扩张症,其中26名(26/26,100%)经胸部X线片诊断,10名(10/26,38.4%)经胸部CT扫描确诊,3名(3/26,11.5%)经组织学确诊。支气管扩张症诊断时的中位年龄为7.5岁(范围1至16岁)。16名LIP患儿出现支气管扩张症(16/47,34.0%)。3名复发性肺炎患者(3/24,12.5%)出现支气管扩张症。5名未愈肺炎患者(5/18,27.7%)出现支气管扩张症。1名婴儿在患卡氏肺孢子虫肺炎后出现支气管扩张症;另1名儿童在患卡氏肺孢子虫和结核分枝杆菌肺炎后出现支气管扩张症。26名支气管扩张症确诊患者中有23名在确诊前6个月内检测了CD4 + T细胞计数,所有患者计数均低于每立方毫米100个细胞。
根据我们的经验,我们得出结论,艾滋病和肺部疾病儿童中支气管扩张症的发生率较高,尤其是在患有LIP、复发性肺炎和未愈肺炎且CD4 + T细胞计数低于每立方毫米100个细胞的儿童中。